Clopidogrel after coronary artery bypass graft surgery: insufficient evidence.

  title={Clopidogrel after coronary artery bypass graft surgery: insufficient evidence.},
  author={Alexander Kulik and Marc A Ruel},
  journal={Journal of the American College of Cardiology},
  volume={58 10},
  pages={1084-5; author reply 1085-6}
The TIMI (Thrombolysis In Myocardial Infarction) investigators did, in fact, assess ischemic episodes throughout the recording period and found that there was not a significant difference in the rate of positive ECG recordings for ischemia (19.9% on ranolazine vs. 21.0% on placebo; p 0.21) (3). The investigators did not specifically report the individual number of symptomatic and silent episodes of myocardial ischemia or their duration during ECG monitoring on ranolazine versus placebo. The… CONTINUE READING
1 Citations
15 References
Similar Papers


Publications citing this paper.


Publications referenced by this paper.
Showing 1-10 of 15 references

Efficacy of postoperative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction

  • R Sørensen, SZ Abildstrom, PR Hansen
  • J Am Coll Cardiol
  • 2011
3 Excerpts

Similar Papers

Loading similar papers…